Viva Vax Overview
- Year Founded
-
2016
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Viva Vax General Information
Description
Manufacturer of protective coatings intended to increase the durability of glass surfaces. The company develops a line of performance coatings for glass surfaces that enhance the durability of glass vials, enabling clients to protect drug content from heat during transport and storage and easily operates a biotechnology facility that leverages deep-science technologies to enhance drug delivery.
Contact Information
Website
www.vivavax.orgCorporate Office
- 44 Gerrard Street East
- Toronto, Ontario M5B 1G3
- Canada
Corporate Office
- 44 Gerrard Street East
- Toronto, Ontario M5B 1G3
- Canada
Viva Vax Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Out of Business | 02-Jul-2024 | Completed | Out of Business | |||
| 5. Accelerator/Incubator | 27-Jun-2019 | Completed | Startup | |||
| 4. Accelerator/Incubator | 01-Jan-2019 | Completed | Startup | |||
| 3. Accelerator/Incubator | 01-Jan-2019 | Completed | Startup | |||
| 2. Accelerator/Incubator | 09-Oct-2017 | Completed | Startup | |||
| 1. Accelerator/Incubator | 01-Jan-2016 | Completed | Startup |
Viva Vax Patents
Viva Vax Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3123892-A1 | Polyurethane with high heat tolerance and other desirable properties including transparency, surface smoothness, desirable adhesiveness, resistance to impact damage, scratches and moisture, and method and use thereof | Inactive | 07-Jul-2020 | ||
| WO-2020107105-A1 | A gelation/de-gelation system for transdermal delivery of an active ingredient (or substrate) | Inactive | 26-Nov-2018 | ||
| JP-2021502278-A | Insulation-imparting sugar-based composition and its usage | Pending | 02-Nov-2017 | ||
| CA-3079988-A1 | Saccharide-based composition for providing thermal insulation and method of use thereof | Inactive | 02-Nov-2017 | ||
| US-20190127590-A1 | Saccharide-based composition for providing thermal insulation and method of use thereof | Inactive | 02-Nov-2017 | C09D5/00 |
Viva Vax FAQs
-
When was Viva Vax founded?
Viva Vax was founded in 2016.
-
Where is Viva Vax headquartered?
Viva Vax is headquartered in Toronto, Canada.
-
What industry is Viva Vax in?
Viva Vax’s primary industry is Industrial Chemicals.
-
Is Viva Vax a private or public company?
Viva Vax is a Private company.
-
What is Viva Vax’s current revenue?
The current revenue for Viva Vax is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process